Can the interim fluorodeoxyglucose-positron emission tomography standardized uptake value be used to determine the need for residual mass biopsy after dose-dense immunochemotherapy for advanced diffuse large B-cell lymphoma?
第一作者:
Malik E,Juweid
作者:
医学主题词
抗肿瘤药(Antineoplastic Agents);活组织检查(Biopsy);氟脱氧葡萄糖F18(Fluorodeoxyglucose F18);人类(Humans);免疫疗法(Immunotherapy);淋巴瘤, 大B细胞, 弥漫性(Lymphoma, Large B-Cell, Diffuse);正电子发射断层显像术(Positron-Emission Tomography);放射性药物(Radiopharmaceuticals)
DOI
10.1200/JCO.2010.30.4394
PMID
20733137
发布时间
2021-10-20
- 浏览8
Journal of clinical oncology
e719-20; author reply e721-2页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



